Bernard Denoyer
Director/Board Member presso OKYO PHARMA LIMITED
Patrimonio netto: - $ in data 30/04/2024
Profilo
Bernard F.
Denoyer is currently a Non-Executive Director at OKYO Pharma Ltd.
He is also a Trustee at St. Edmunds Retreat, Inc. and Midwestern Connecticut Council of Alcoholism, Inc. In the past, he worked as the Chief Financial Officer & Senior Vice President at META Group, Inc. and as the Chief Financial Officer, Secretary & Senior VP at Callisto Pharmaceuticals, Inc. He was also a Vice President-Finance at Environetics, Inc. and a Secretary & Senior Vice President at Synergy Pharmaceuticals LLC.
Additionally, he served as a Trustee at Pawfect Foods, Inc. and as the Chief Financial Officer, Secretary & Senior VP at Hepion Pharmaceuticals, Inc. Mr. Denoyer received his undergraduate degree from Fairfield University and his MBA degree from Columbia Business School.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
OKYO PHARMA LIMITED
-.--% | 28/07/2023 | 0 ( -.--% ) | - $ | 30/04/2024 |
Posizioni attive di Bernard Denoyer
Società | Posizione | Inizio |
---|---|---|
OKYO PHARMA LIMITED | Director/Board Member | 01/12/2021 |
St. Edmunds Retreat, Inc. | Director/Board Member | - |
Midwestern Connecticut Council of Alcoholism, Inc. | Director/Board Member | - |
Precedenti posizioni note di Bernard Denoyer
Società | Posizione | Fine |
---|---|---|
SYNERGY PHARMACEUTICALS INC | Director of Finance/CFO | 17/04/2017 |
HEPION PHARMACEUTICALS, INC. | Director of Finance/CFO | 23/06/2014 |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | Director of Finance/CFO | 22/01/2013 |
Pawfect Foods, Inc. | Director of Finance/CFO | 11/08/2008 |
META Group, Inc.
META Group, Inc. Miscellaneous Commercial ServicesCommercial Services META Group, Inc. provides research and analysis for information technology trends & markets. The firm's advisory services, which include research, on-site briefings, strategic plan reviews, phone consultations and conferences. It is specialized in enterprise architecture, e-commerce and global networking, as well as industry-specific programs. The company was founded in 1989 and is headquartered in Stamford, CT. | Director of Finance/CFO | 01/09/2000 |
Formazione di Bernard Denoyer
Fairfield University | Undergraduate Degree |
Columbia Business School | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
OKYO PHARMA LIMITED | Health Technology |
HEPION PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 7 |
---|---|
META Group, Inc.
META Group, Inc. Miscellaneous Commercial ServicesCommercial Services META Group, Inc. provides research and analysis for information technology trends & markets. The firm's advisory services, which include research, on-site briefings, strategic plan reviews, phone consultations and conferences. It is specialized in enterprise architecture, e-commerce and global networking, as well as industry-specific programs. The company was founded in 1989 and is headquartered in Stamford, CT. | Commercial Services |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | Health Technology |
Pawfect Foods, Inc. | Retail Trade |
Environetics, Inc.
Environetics, Inc. Wholesale DistributorsDistribution Services Part of Alanco Technologies, Inc., Environetics, Inc. is committed to improving water quality through the development of products which help to solve industrial and municipal water and wastewater quality problems. The private company is based in Scottsdale, AZ. The company produces tank & clearwell baffles and covers that provide practical solutions for improving water, wastewater, and air quality. Environetics improves waste treatment by offering a quick, efficient, and satisfactory way to upgrade tank based waste treatment operations through the installation of a Director II system. Environetics was acquired by Alanco Technologies, Inc. on January 06, 1995. | Distribution Services |
St. Edmunds Retreat, Inc. | |
Midwestern Connecticut Council of Alcoholism, Inc. | |
Synergy Pharmaceuticals LLC
Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY. | Health Technology |
- Borsa valori
- Insiders
- Bernard Denoyer